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Abstract.  Microinjection of the catalytic subunit of 
cAMP-dependent protein kinase (A-kinase) into living 
fibroblasts or the treatment of these cells with agents 
that elevate the intracellular  cAMP level caused marked 
alterations  in cell morphology including a rounded 
phenotype and a complete loss of actin microfilament 
bundles.  These effects were transient and fully revers- 
ible. Two-dimensional gel electrophoresis was used to 
analyze the changes in phosphoproteins from cells in- 
jected with A-kinase.  These experiments showed that 
accompanying the disassembly of actin microfilaments, 
phosphorylation of myosin light chain kinase (MLCK) 
increased and concomitantly, the phosphorylation of 
myosin P-light chain decreased.  Moreover, inhibiting 
MLCK activity via microinjection of affinity-purified 
antibodies specific to native MLCK caused a complete 
loss of microfilament bundle integrity and a decrease 
in myosin P-light chain phosphorylation,  similar to 
that seen after injection of A-kinase.  These data sup- 
port the idea that A-kinase may regulate microfilament 
integrity through the phosphorylation and inhibition  of 
MLCK activity in nonmuscle cells. 
C 
YCLIC AMP is a key second messenger which medi- 
ates the biological effects of B-adrenergic  hormones 
(for reviews see references 19, 20). These hormones 
activate adenylate cyclase, catalyzing the production of intra- 
cellular cAMP. The mode of action of cAMP is thought  to 
be solely through the activation of the cAMP-dependent  pro- 
tein  kinase  (A-kinase) ~ by promoting  the  dissociation  of 
inactive holozyme into regulatory subunits  and active cata- 
lytic subunits  (reviewed in reference 34). The catalytic  sub- 
units  catalyze the phosphorylation of certain  protein  sub- 
strates which serve,  in many cases, to regulate their subse- 
quent biological activity (for reviews see references  19, 20, 
34, 40, 59). Glycogen metabolism is tl~e best-characterized 
process regulated by B-adrenergic  agents and A-kinase.  For 
example, the activation of A-kinase by the hormone epineph- 
rine  results  in  a  cascade of phosphorylation  of enzymes 
which leads to the breakdown of glycogen to glucose 1-phos- 
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phate. In addition to its regulatory role in glycogen metabo- 
lism, A-kinase also has been implicated in mediating a num- 
ber of other intracellular  events including  the regulation  of 
cell shape (43, 44, 53, 72), cell motility (5), and the control 
of cell growth and proliferation  (42, 49, 74). 
Several studies  have indicated  a role for A-kinase  in the 
regulation  of cytoskeletal  structure (5, 53).  The control of 
smooth muscle and nonmuscle microfilament  (MF) contrac- 
tion  via  phosphorylation  of  myosin  light  chain  kinase 
(MLCK) by A-kinase has also been suggested (2, 21, 39, 55, 
57, 66). In addition,  changes in intermediate  filament orga- 
nization  (such as those that  occur during  mitosis)  may be 
mediated by the phosphorylation of vimentin  catalyzed  by 
A-kinase  (12,  14,  17, 30-33, 41, 64). Likewise,  there have 
been reports suggesting  that  changes  in cell shape  may be 
influenced  by  phosphorylation  of microtubule-associated 
proteins  by A-kinase  (13, 46, 62). 
In the present studies,  we have examined the role of A-ki- 
nase in the regulation  of actin MF structure and function in 
nonmuscle cells. In contrast to skeletal muscle,  actin-myo- 
sin interaction  in smooth and nonmuscle cells appears to be 
controlled by the phosphorylation of the myosin P-light chain 
(MLC) (23, 50, 51, 58; for reviews see references 22, 35, 39, 
57). The phosphorylation of myosin light chain is catalyzed 
by the enzyme MLCK, the activity of which is dependent 
upon calcium and calmodulin, which serve as cofactors (21, 
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hibited in vitro and in vivo by phosphorylation of the enzyme 
catalyzed by A-kinase (21, 26,  60).  This phosphorylation 
interferes  with  Ca÷+/calmodulin  binding  to  MLCK  and 
thereby results in the inhibition of MLCK activity in vitro 
(reviewed in reference 1). 
In an effort to examine the possible role of A-kinase in the 
regulation of MLCK and actin MF structure/function in liv- 
ing nonmuscle cells, we examined the effects of activating 
A-kinase in cells by raising intracellular cAMP levels using 
defined drugs or by directly microinjecting the purified A-ki- 
nase catalytic subunit into living fibroblasts. We show that 
within 30 min after elevation of A-kinase activity, virtually 
all of the MF bundles are disrupted. Moreover, we provide 
evidence that these changes in actin MF integrity after A-ki- 
nase elevation are temporally accompanied by both an in- 
crease  in  MLCK phosphorylation and a  concomitant de- 
crease in level of myosin light chain phosphorylation. These 
results support the model suggested previously for the regu- 
lation of smooth muscle actomyosin structure/function in 
which phosphorylation and subsequent inhibition of MLCK 
activity is catalyzed by A-kinase in nonmuscle cells. 
Materials and Methods 
Cell Culture 
Rat embryo fibroblast (REF-52) cells were cultured in a  humidified at- 
mosphere containing 5 % CO2, 95 % air as described previously (45). Cells 
were plated 2-3 d before use for microinjection (69). 
Isolation of  A-Kinase and Purification of 
the Catalytic Subunit 
The free catalytic subunit of the A-kinase was purified from bovine heart 
(9). Purified catalytic subunit was stored as stock solution at 4°C in 5.0 mM 
2-[N-morpholino]ethanesulphonic acid (pH 6.5),  100 mM NaCI, 0.2 mM 
EDTA,  15 mM beta-mercaptoethanol. 
Drug Studies 
REF-52 cells growing on glass coverslips were incubated with a mixture of 
dibutyryl cAMP (db-cAMP) and 3-isobutyl-l-methylxanthine (MIX) (both 
from Sigma Chemical Co., St. Louis, MO). Drugs were used at a concen- 
tration of 1 mM final, diluted from 1.0-M DMSO stock solutions. Solutions 
containing the same amount of DMSO without drugs were used as controls. 
After the appropriate incubation period, the cells were analyzed by phase- 
contrast microscopy. Alternatively, the cells were fixed and the distribution 
of the  actin  microfilaments determined by  incubation  with  rhodamine- 
conjugated phalloidin (rh-phalloidin) (generously provided by T. Wheiland, 
Max-Planck-lnstitut,  Heidelberg,  Federal  Republic of Germany) as de- 
scribed below. 
Microinjection and Immunofluorescence 
Cells were microinjected as described by Feramisco (27) using glass capil- 
lary  needles. The purified A-kinase catalytic subunit was diluted to  1.0 
mg/ml into an injection buffer (100 mM potassium glutamate, 40 mM potas- 
sium citrate,  1.0 mM MgCI2, pH 7.2).  As it is estimated that the level of 
A-kinase in cells is ~0.2-2.0 p.M (8), and we are injecting a 25-1xM solution 
of the catalytic subunit which is diluted 20-fold by injection, we estimate 
that the microinjection procedure elevates the endogenous level of A-kinase 
by three-to-fivefold. Active MLCK was purified from bovine trachea as de- 
scribed elsewhere (2),  before conjugation to Affigel (20 mg MLCK/ml 
Affigel). A  42%  ammonium sulfate  fraction of whole serum  (*5  nag) 
directed against smooth muscle MLCK was affinity purified against native 
MLCK before being dialyzed against PBS (137 mM NaCI, 2.7 mM KCI, 
1.5 mM KH2PO4,  8.0 mM Na2HPO4).  Affinity-purified anti-MLCK and 
other monospecific antibodies were concentrated by sucrose dialysis (to 1-5 
mg/ml) before being dialyzed into 0.5  x  PBS for microinjection. For ira- 
munofluorescence, cells were fixed for 5 min in 3.7% formalin (in PBS) fol- 
lowed by a 30-s extraction in -20°C acetone before staining for actin. Actin 
MFs were visualized with rh-phalloidin a  specific stain for F-actin (73). 
Cells injected with primary antibodies directed against MLCK or control 
proteins were incubated for 60 rain before fixation and extraction as de- 
scribed above. Injected antibodies were subsequently visualized by a 30-rain 
incubation with afffinity-purified fluorescein-conjugated  goat anti-rabbit an- 
tibody (CooperBiomedical, Inc., Malvern, PA) diluted 1:100. Cells were 
simultaneously stained for actin MFs with rh-phalloidin. The cells were 
analyzed on a photomicroscope (model III, Carl Zeiss, Inc., Thornwood, 
New York) using a 63x  (1.3 NA) lens. Fluorescent images were recorded 
onto Kodak Tri-X pan (developed in Diafine; Acufine, Inc., Chicago, IL) 
and phase images on Kodak 2415 technical pan (developed in Rodinal; Agfa- 
Gevaert, Teterboro, N J). 
Metabolic Pulse Labeling 
Microinjection studies involving metabolic pulse labeling used small (1- 
mm  2) glass coverslips ("chips")  onto which cells were plated and allowed 
to grow for 2-3 d. Coverslips having approximately the same number of 
cells were selected and microinjected with either purified A-kinase, antibod- 
ies specific to MLCK, or control solutions. Precisely the same number of 
cells on each chip were injected and any residual uninjected cells removed 
by scraping with the micropipette. After injection, the chips were trans- 
ferred to humidified chambers for ;¢arying periods of time. For labeling, the 
chips were washed once in phosphate-free DME and then incubated for 30- 
min periods in 5 ~tl of phosphate-free DME (supplemented with dialyzed 
serum to  10%)  containing 250-500  ~tCi [32P]H3PO4 (carrier free; Amer- 
sham International, Amersham, United Kingdom). Gard and Lazarides (31) 
have shown that the specific activity of [32p]ATP achieved in cells after in- 
cubation with [32P]H3PO4 does not change appreciably after activation of 
A-kinase. Because of the prohibitively small sample size of microinjected 
cells, it was not feasible to determine the specific activity of  the radiolabeled 
ATP in these samples directly.  However, the phosphoprotein changes in 
REF-52 cells induced by either injection of A-kinase or by the addition of 
cell-permeable cAMP analogues to the culture medium were similar to 
those reported by Gard and Lazarides (31), suggesting that the procedures 
used in the present study are valid. After the labeling period, the cells were 
briefly washed twice in DME lacking phosphate and transferred to Eppen- 
doff tubes containing '~5  ×  106 unlabeled cells in 20 ~tl of sample buffer 
(62.5 mM Tris-Cl [pH 6.8], 5 mM dithiothreitol [DTTI, 0.5% [wt/vol] SDS, 
7.5%  [wt/vol] glycerol, and 2%  [wt/vol] NP-40).  After boiling, samples 
were lyophilized and resuspended in  10  ~tl of 1.0 mg/ml DNase and  1.0 
mg/ml RNase in 50 mM Tris-Cl (pH 7.4),  10 mM MgCI2, and incubated 
for 5 min at 37°C to digest nucleic acids. Samples were then diluted with 
IEF sample buffer (9.5 M urea, 2% [wt/vol] NP-40, 5% [wt/vol] beta-mer- 
captoethanol, 2 % [wt/vol] 6-8 ampholines) such that the final concentration 
of SDS was <0.1%  (wt/vol). 
Two-dimensional Gel Electrophoresis 
Samples were analyzed by two-dimensional electrophoresis using the meth- 
od of O'Farrell (48). First dimension electrofocusing gels contained 9.5 M 
urea 2% (wt/vol) ampholines, 2% (wt/vol) NP-40, and 5% (wt/vol) DTT. 
The ratio of ampholines was varied in the electrofocusing gel mixture to 
facilitate better resolution of  different cellular protein components. The mix- 
tures used were 60 % (wt/vol) ampholine pH 3-10, 40 % (wt/vol) ampholine 
pH 5-7 for resolving the whole cellular protein mixture, 50% (wt/vol) am- 
pholine pH 4-6, 50%  (wt/vol) ampholine pH 5-7, to resolve myosin light 
chain and 50% (wt/vol) ampholine pH 5-7, 50% (wt/vol) ampholine pH 6-8 
to resolve MLCK. Second dimension gels contained either 12.5  or 15% 
(wt/vol) acrylamide and 0.1% (wt/vol) bis-acrylamide (11). Immediately af- 
ter electrophoresis the gels were either processed for electrophoretic trans- 
fer (see below) or fixed in 50% (wt/vol) TCA at 70°C to hydrolyze residual 
nucleic acid and then stained to visualize the molecular mass markers. After 
drying, the phosphoproteins were visualized by autoradiography at -70°C 
on Kodak XAR-5 flm, using Cronex Lightening Plus intensifying screens. 
Electrophoretic Transfer and Immunoblotting 
Immediately after electrophoresis in the second dimension, proteins were 
electrophoretically transferred to  nitrocellulose as  described previously 
(15). For MLCK, gels were transferred for 24 h at 50 V; whereas for myosin 
light chain, transfer was complete within 90 min at 80 V. (This difference 
reflects the slower rate at which MLCK transfers.) On completion of the 
transfer, nitrocellulose sheets were incubated with 1% (wt/vol) BSA to block 
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rabbit anti-myosin light chain antibodies (50) (kindly provided by J. Stull, 
University of Texas,  Dallas, Texas)  diluted 1:100 in PBS/BSA (PBS sup- 
plemented with 0.05%  [wt/vol] BSA) or rabbit MLCK antibodies, diluted 
1:100 into PBS/BSA. Primary antibodies were visualized by incubation with 
an afffinity-purified horseradish peroxidase-conjugated goat anti-rabbit anti- 
body (Cooper Biomedical, Inc.) diluted 1:1,000, before subsequent color de- 
velopment with 4-chloronapthol (Sigma Chemical Corp.) (0.3 % lwt/voll in 
methanol) diluted  1:15 in PBS containing 20 Ixl H202.  In all cases, after 
electrophoretic transfer the gels were stained and processed for autoradiog- 
raphy as described above to ensure that protein transfer had been fully effec- 
tive. In no case did any phosphoproteins other than residual vimentin re- 
main in the gel. 
Electron Microscopy 
Cells were grown on UV-sterilized formvar-coated glass coverslips. After 
injection of A-kinase, the cells were fixed for 20  rain with 2%  (wt/vol) 
glutaraldehyde in PBS with further fixation in 75 mM eacodylate (pH 7.4) 
supplemented with 4.5% (wt/vol) sucrose. Cells were washed with PBS and 
fixed afterward with 1% (wt/vol) OsO4 in 75 mM cacodylate (pH 7.4) for 
10 min. After a water wash, the cells were stained with saturated aqueous 
uranyl acetate for 5 min. After staining and washing in water, the formvar 
was stripped from the coverslip, inverted, and raised to the water surface. 
Copper grids were placed over the injected cells and after serial ethanol de- 
hydration, cells were critical point dried in a Bomar SPC-900 using CO2 
as the transitional fluid.  Cells were analyzed on an electron microscope 
(model 200ZX; Philips Electronic Instruments, Inc., Mahwah, NJ) at 100 
kV. 
Results 
Morphological Changes in Cells Treated with Drugs 
that Activate Endogenous A-Kinase 
Initial experiments were performed to assess the morpholog- 
ical consequences of elevating endogenous A-kinase levels in 
REF-52 cells. For these studies we used, simultaneously, two 
drugs  that  freely pass  into  cells  and  elevate  intracellular 
cAMP levels:  (a)  db-cAMP,  an analog of cAMP,  and (b) 
MIX, an inhibitor of the cyclic nucleotide phosphodiester- 
ases. REF-52 cells, growing on 35-mm dishes (Falcon Lab- 
ware, Oxnard, CA), were incubated in the presence of both 
1 mM db-cAMP and 1 mM MIX. After a 60-min incubation 
period at 37°C,  marked alterations in cellular morphology 
were observed (Fig.  1). The most obvious changes entailed 
a rapid "rounding" of the cells involving a pronounced thick- 
ening around the nucleus, a reduction in cytoplasmic phase 
detail,  and  a  corresponding  appearance  of  phase-dense 
regions in the cell periphery. The rounding effect observed 
in these experiments appears only to involve a change in cell 
morphology,  with  the  cells  showing no  apparent  loss  of 
contact with the substratum and therefore remaining well 
spread.  (In this work, the term "rounding" refers solely to 
this perinuclear thickening and loss of phase detail.) These 
effects on cell morphology were fully reversible.  If  the drugs 
were removed after a 60-rain incubation period and the cells 
further incubated in normal medium,  they regained their 
well-spread and flattened morphology within '~3-6 h (data 
not shown, but see below). In other experiments we have de- 
termined that these drug-induced changes in cell morphol- 
ogy can be maintained for up to 20 h provided that the cells 
are  maintained in  the presence  of the  drugs.  Again,  the 
effects can be reversed by simple removal of the drugs. In ad- 
dition, little or no cell death was observed as a result of the 
drug treatment. Finally, both the extent and kinetics of such 
morphological changes appeared dependent upon the con- 
centrations of  the drugs used. At higher concentrations of the 
drugs (e.g., >1 mM), there occurred a more rapid rounding 
of the cells; however,  the overall extent of the changes ap- 
peared similar to that observed when using lower concentra- 
tions (e.g., 1 mM) of each drug. Conversely, lower concen- 
trations of the drugs (<1  mM) induced progressively less 
dramatic changes in cellular morphology with the kinetics 
of such changes being somewhat slower. Similar morpholog- 
ical  changes  were observed when another cAMP analog, 
8-bromo-cAMP, was used to treat the cells. 
Because of the intimate relationship between cell shape 
and  the  organization  of  the  cytoskeleton,  we  examined 
whether alterations in the integrity of the cytoskeleton might 
accompany the morphological changes observed after drug 
treatment.  Particular attention was paid to the actin MFs 
since previous studies had demonstrated similar changes in 
cell morphology after treatment with agents (e.g., cytochala- 
sins) that perturb MF organization (10, 52, 54, 70; reviewed 
in references 65,  71)  or treatment with hormones that in- 
crease cAMP (5). REF-52 cells, growing on glass coverslips, 
were incubated with 1 mM db-cAMP and 1 mM MIX for 60 
min and then fixed; alternatively, the drugs were removed 
and the cells were incubated in drug-free medium for an ad- 
ditional 90 min before fixation. The distribution of the actin- 
containing MFs was analyzed by incubation with rh-phalloi- 
din, an agent that binds specifically to F-actin (73).  Shown 
in Fig. 2 A are the control cells (no drug treatment) stained 
for the distribution of the actin MFs. A rather typical distri- 
bution of the actin MFs and the stress fibers was observed. 
In contrast, the majority of those cells incubated in the pres- 
ence of the drugs (>170%) no longer displayed any fibrillar 
actin MF bundles. Instead only residual punctate actin stain- 
ing could be observed near the cell periphery and in some 
cases very near the nucleus (Fig. 2 D).  Some of the cells 
(such as the cells seen in the upper right of Fig. 2 D) dis- 
played residual stress fiber bundles for reasons as yet un- 
known. Removal of the drugs and further incubation of the 
cells in complete medium resulted in a gradual restoration 
of  their normal cell morphology and an accompanying return 
of normal MF organization. For example, in cells allowed to 
recover from the drugs for 90 min a partial return of normal 
actin MF staining was observed throughout the cytoplasm 
(Fig. 2 F). By 6 h of recovery, the distribution of actin fila- 
ments appeared identical to that of the cells exposed to the 
drugs (data not shown). 
Morphological Changes in Living Fibroblasts after 
Microinjection of  the Catalytic Subunit of  A-Kinase 
Although db-cAMP and MIX have the overall effect of ele- 
vating intracellular cAMP levels and activating endogenous 
A-kinase, we were concerned that they may have other effects 
as well. Therefore, to ascertain in a direct fashion whether 
A-kinase might be involved in these changes in cell morphol- 
ogy and actin filament integrity, we examined the conse- 
quences of elevating intracellular A-kinase activity directly 
by microinjection of the purified catalytic subunit into the 
cytoplasm of living cells. Different amounts of the enzyme 
were used in initial experiments. Concentrations of <5 mg/ 
ml were tested, and we decided to routinely use a concentra- 
tion of 1 mg/ml purified catalytic subunit. As discussed in 
Materials and Methods, we estimate that injection of such a 
Lamb et al.  cAMP-dependent  Kinase and Microfilament  Integrity  1957 Figure  1.  Changes in cellular  morphology  after treatment  of cells with db-cAMP and MIX. Endogenous A-kinase activity levels were 
elevated by treating REF-42 cells with 1 mM db-cAMP (a freely cell-soluble analogue of cAMP) and 1 mM MIX (an inhibitor of the cAMP 
phosphodiesterase).  After a 60-min exposure to the drugs, changes in cell morphology were recorded by phase-contrast microscopy. (A) 
Cells before the addition of the drugs.  (B) Cells after a 60-rain exposure to the drugs. Bar, 20 lam. 
solution  of catalytic  subunit  results  in  an  elevation of the 
A-kinase level to three to five times the maximal level of ac- 
tive catalytic subunits that could be obtained by stimulation 
of the endogenous A-kinase in cells. 
Within  30 min after injection of A-kinase, REF-52 cells 
began to displa~ an exaggerated thickening (rounding) near 
the cell nucleus (Fig. 3 b). In addition, regions near the cell 
periphery appeared more pronounced or phase dense. These 
morphological changes after microinjection of the purified 
A-kinase appeared very similar to those observed in  cells 
treated with db-cAMP and MIX (e.g., compare this to Fig. 
1,  but  note  that  the  cells  were  photographed  at  higher 
The Journal of Cell Biology, Volume  106,  1988  1958 Figure 2.  Treatment of cells with db-cAMP and MIX results in reversible changes in the integrity of the actin microfilaments. REF-52 
cells, growing on glass coverslips, were treated with 1 mM db-cAMP and 1 mM MIX. After a 60-min exposure, one coverslip was removed 
and fixed with formalin as described in Materials and Methods. For the remaining cells, the medium containing the drugs was removed, 
the cells were washed three times with fresh culture medium, and then further incubated in the same for 90 min. These cells were then 
fixed with formalin and analyzed for the distribution of actin.  Staining of the actin MFs was determined using rh-phailoidin as described 
in Materials and Methods. A, C, and E are the phase-contrast micrographs and B, D, and F are the corresponding fluorescent micrographs. 
(A and B) Untreated cells. (C and D) Cells treated with drugs for 60 min. (E and F) Cells after treatment with drugs for 60 min, removal 
of drugs,  and further  incubation for 90 min.  Bar, 10 p.m. 
magnification in Fig.  1). Moreover, the changes induced by 
microinjection of the catalytic subunit were also transient, by 
24 h after injection the cells had regained their normal and 
well-spread character (Fig. 3 c). Microinjection of compara- 
ble  amounts  of BSA  or  A-kinase  inactivated  by  multiple 
rounds of freezing and thawing had no effect on the morphol- 
ogy of the cells. Finally, injection of lower concentrations of 
the enzyme resulted in both a  slower rate of change in cell 
morphology as well as a faster recovery of the cells to their 
normal morphology (data not shown). 
Having  demonstrated  that  microinjection  of exogenous 
A-kinase into living cells resulted in morphological changes 
similar to  that  observed after  treatment  of the  cells  with 
drugs that activate endogenous A-kinase, we next examined 
whether  similar changes  would  occur  with  respect to  the 
structure of the actin MFs (Fig. 4). Within 30 min after injec- 
tion of A-kinase, the  MF bundles  (visualized again by rh- 
phalloidin) were reduced in both their number and apparent 
thickness (Fig. 4,  C and D).  By 60 min after injection the 
cells had become maximally rounded and displayed virtually 
no MF bundles  (Fig.  4,  E  and F). 
Indirect immunofluorescence analyses of the A-kinase in- 
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croinjection of purified A-kinase. Approximately 25 
REF-52 cells,  growing on 35-mm Falcon dishes, 
were  injected  with  a  1.0-mg/ml solution  of the 
purified catalytic subunit of A-kinase. (The injected 
cells were marked by first placing an ink circle on 
the bottom of the culture dish.) Changes in the mor- 
phology of the living cells after microinjection were 
monitored by phase-contrast microscopy. (a) Cells 
before injection. (b) Cells 60 min after injection of 
the purified A-kinase. (c) Cells 24 h after injection 
of the purified A-kinase. Bar, 30 p,m. 
jected cells using a variety of different antibodies specific to 
other MF-associated proteins (e.g., ¢t-actinin,  MLCK, myo- 
sin heavy chain, and tropomyosin) demonstrated the loss of 
intact MFs (data not shown). Further confirmation of the dis- 
solution of the actin MFs was obtained by analyzing microin- 
jected cells via whole mount EM (Fig.  5). While cells in- 
jected  with  the  microinjection  buffer  alone  displayed  a 
typical pattern of MF bundles traversing the cytoplasm (Fig. 
5 A),  those cells injected with the purified kinase showed 
virtually no discernible 6-nm filaments (Fig. 5 B). Since the 
The Journal of Cell Biology, Volume  106, 1988  1960 Figure 4. Changes in the integrity of MFs after microinjection of A-kinase. Subconfluent REF-52 cells, growing on glass coverslips, were 
injected with a 1.0-mg/ml solution of the purified catalytic subunit of A-kinase. At various times afterward,  the cells were fixed and the 
distribution of  the actin MFs was analyzed by incubation with rh-phalloidin.  Shown are phase-contrast (A, C, and E) and the corresponding 
fluorescence (B, D, and F) micrographs of cells analyzed for the distribution of actin. (A and B) Control cells injected with microinjection 
buffer alone. (Cand D) Cells injected with purified A-kinase and further incubated for 30 min. (Eand F) Ceils injected with purified A-kinase 
and further  incubated for 60 min.  Bar, 10 lam. 
fixation conditions for EM are different (2 % glutaraldehyde) 
from those used for fluorescence, these findings support the 
conclusion that the injection of A-kinase results in the dis- 
ruption of the ME 
To determine whether these alterations in the integrity of 
the MFs were reversible, we performed a time course experi- 
ment analyzing the cells at various times after injection of 
the purified kinase.  REF-52 ceils were injected with a  1.0- 
mg/ml solution of the kinase and at various times thereafter 
the cells examined by phase-contrast and fluorescence mi- 
croscopy for the distribution  of the actin MFs (Fig.  6).  90 
min after injection,  the cells were still rounded and devoid 
of most of their fibrillar actin (Fig.  6,  A and B).  3 h  after 
injection the cells had begun to respread and exhibited a par- 
tial return of their actin MF bundles (Fig. 6,  C and D). By 
30 h after injection, both cell morphology and the distribu- 
tion of actin appeared indistinguishable from that of the con- 
trol cells (Fig.  6,  E  and F). 
Lamb et al. cAMP-dependent Kinase and Microfilament Integrity  1961 Figure 5. Analysis of cells microinjected with A-kinase by whole mount EM. REF-52 cells growing on formvar-coated  glass coverslips 
were injected with the purified A-kinase catalytic subunit (1 mg/ml)  or with microinjection buffer alone. 60 min after injection the cells 
were fixed and analyzed by whole mount EM as described in Materials and Methods. (A) A single cell injected with microinjection buffer 
alone. (B) A single cell injected with the purified catalytic subunit. Bar, 10 ~tm. 
Phosphoprotein Changes in Cells Injected with A-Kinase 
As the mechanism of action of A-kinase is presumably via 
phosphorylation of substrate proteins, changes in the phos- 
phorylation status of cellular proteins after microinjection of 
A-kinase were examined. For these studies, ceils were plated 
on small 1-mm  2 glass coverslips.  Each and every cell on a 
coverslip was  injected either with the kinase or with the 
microinjection buffer alone, and at various times thereafter 
the cells were metabolically labeled with [32p]H3PO4. After 
the labeling period the cells were solubilized and the labeled 
proteins analyzed by two-dimensional gel electrophoresis. 
The phosphoproteins were visualized by autoradiography of 
the gels (exposure times of 3-14 d with an enhancing screen). 
The phosphoprotein pattern of cells (,,0100 cells total) in- 
jected with buffer (i.e., control) and pulse labeled for the 
period 30-60 rain after injection are shown in Fig. 7 A. This 
pattern appears similar to the typical phosphoprotein pattern 
obtained by labeling a whole dish of cells, indicating that the 
microinjection procedures alone have no effect on the phos- 
phoprotein pattern. After injection of A-kinase, an overall in- 
crease in protein phosphorylation was observed within the 
first 30 min (Fig. 7 B). Although at least 20 protein species 
showed changes  in their phosphorylation status, the most 
prominent increase in phosphorylation occurred on vimentin 
(V) and two proteins that we have identified as the nuclear 
lamins A and C (L in Fig. 7). Similar changes in phosphory- 
lation of both these proteins have been reported previously 
in cells treated with drugs or hormones that elevate cAMP 
(14, 30, 31, 33, 41). Our assignment of the positions of both 
vimentin and the nuclear lamins were confirmed by immuno- 
blotting with the appropriate monospecific antibodies (data 
not shown). Cells labeled 30-60 min after injection (i.e., the 
period during which the major changes in cell morphology 
and actin organization occur) displayed both the maximal 
levels of protein phosphorylation and a number of new phos- 
phoproteins (at least five) not apparent in the previous 30- 
min labeling period (Fig. 7 C). Labeling during the period 
60-90 min after injection showed a gradual decrease in over- 
all protein phosphorylation as compared to the levels  ob- 
served during the previous time periods (Fig. 7 D). 
Since a number of  phosphoproteins including myosin light 
and heavy chain and MLCK have been identified as key pro- 
teins in the regulation of actomyosin contractility, we chose 
to further analyze whether changes in these phosphoproteins 
The Journal of Cell Biology, Volume  106,  1988  1962 Figure 6. The effects  on actin MF integrity after A-kinase injection are fully reversible. In an experiment similar to that described in Fig. 2, 
REF-52 cells were injected with purified A-kinase and the distribution of the actin MFs was analyzed at various periods after injection 
using rh-phalloidin. Phase-contrast micrographs (A, C, and E) and the corresponding fluorescence micrographs (B, D, and F) of the actin 
MFs are shown. (14 and B) Cells 90 min after injection. (C and D) Cells 180 min after injection. (E and F) Cells 30 h after injection. 
Bar, 10 tam. 
occurred after injection of A-kinase. Because of the low mo- 
lecular mass and expected isoelectric point of MLC, we were 
especially interested in examining proteins of low molecular 
mass that migrated near the acidic end of the gels.  Conse- 
quently, the same gels analyzed in Fig.  7, A-D, were reex- 
posed for a longer period of time and this region of the au- 
toradiograms  (boxed area) was  magnified (E-H).  In  the 
case of cells injected only with the microinjection buffer, a 
prominent ~20 kD protein near the acidic end of the gel was 
apparent.  Owing to its similar size and isoelectric point to 
that reported for the MLC, and its recognition by antibodies 
specific for MLC (see below), we have designated this pro- 
tein as M in the figure. In cells injected with A-kinase and 
labeled 0-30 rain after injection (F) a slight decrease in the 
phosphorylation of M  was observed. Labeling of the cells 
30-60 rain (G) or 60-90 min after injection (H) revealed lit- 
tle or no continued phosphorylation of the M protein. While 
several other proteins exhibited a  similar decreased phos- 
phorylation with time after injection, the overall reduction 
in M  protein phosphorylation appeared prominent. 
Lamb et al. cAMP-dependent Kinase and Microfilament Integrity  1963 Figure 7. Analysis of phosphoprotein changes after microinjection of the catalytic  subunit  of A-kinase.  REF-52 cells,  growing on 1-mm  2 
glass coverslips,  were microinjected with either buffer alone or with a 1.0-mg/ml solution  of the purified  subunit of A-kinase.  (Every cell 
on the coverslip was injected.)  At various times after injection,  the cells were rinsed with DME lacking phosphate and metabolically  labeled 
with [32p]H3PO4  for 30 min.  After the labeling period, the cells were solubilized  in lysis buffer and the labeled proteins  analyzed by two- 
dimensional gel electrophoresis as described in Materials  and Methods.  Shown are autoradiograms  of the gels  (the acidic  end is to the 
left) with the major phosphoproteins vimentin (V) and the nuclear lamins (L) marked (A-D). Because of  the differential levels of  phosphory- 
lation among the various  substrate  proteins,  we have included  longer exposures  (14 d instead of 3 d) of that region of the gel containing 
the putative  myosin light chain (boxed areas of A-D which correspond to E-H, respectively).  (A) Approximately  100 cells injected  with 
microinjection buffer alone and labeled  30-60 min after injection.  (B) Approximately  30 cells  injected  with A-kinase  and labeled  0-30 
min after injection.  (C) Approximately  30 cells injected with A-kinase and labeled 30-60 min after injection.  (D) Approximately  30 ceils 
injected with A-kinase and labeled  60-90 min after injection.  The regions  of the gels containing  the putative  myosin light chain from A, 
B, C, and D are shown respectively  in E, F, G, and H. (E-H) M, the position of the putative myosin light chain; arrowhead, the position 
of a different phosphoprotein in the same region as myosin light chain. (Note that three times  as many ceils were analyzed in panels A 
and E  [control,  microiniection buffer]  owing to the higher incorporation of radiolabel  in those cells  injected  with the A-kinase.) 
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deed the MLC,  Western blot analysis of two-dimensional 
gels  was  carried  out using monospecific antiodies raised 
against the protein purified from smooth muscle (very kindly 
provided by J.  R. Stull and colleagues). In addition, using 
an antibody to the MLCK, we determined its two-dimen- 
sional  coordinates.  In  duplicate,  cells  were  injected with 
purified A-kinase, labeled with [32P]H3PO4 for the period 
30-60 min after injection (when the maximal changes in the 
actin MF organization occur), and then harvested. An ali- 
quot of unlabeled "carrier" cells was added to the radiola- 
beled cells (to allow for Western blot analysis), the proteins 
were separated by two-dimensional gel electrophoresis and 
transferred to nitrocellulose, and the positions of MLC and 
MLCK were determined.  After detection of the antibody 
reaction products, the nitrocellulose sheets were exposed to 
film to reveal the position of the [32p]H3PO4-1abeled pro- 
teins. Fig. 8 A shows the position of the myosin light chain 
as revealed after color development of the blot. Clearly, two 
spots are present which we believe correspond to the phos- 
phorylated and dephosphorylated isoforms of the myosin 
light chain. Fig. 8 B shows the phosphoprotein pattern of  the 
cells injected with buffer. The position of the heavily phos- 
phate-labeled protein indicated corresponded exactly to that 
of  the more abundant and acidic form of  the two myosin light 
chain spots as determined by immunoblotting. In the cells 
injected with A-kinase, this same protein was observed to 
contain significantly less radiolabel (Fig. 8 C). Hence, we 
conclude that the 20-kD protein whose overall incorporation 
of [32p]H3PO4 decreases after A-kinase injection is indeed 
the MLC. We have observed that the extent of MLC phos- 
phorylation decreases with time after A-kinase injection and 
that by 75 min after injection little or no phosphorylation of 
the protein occurs. As was shown earlier, this is the same 
time after injection when the actin MF appeared maximally 
disassembled. 
In the same studies, examining the phosphorylation status 
of MLCK, a  result opposite to that obtained with myosin 
light chain was observed. In Fig. 8 D the position of MLCK, 
as determined by immunoblotting, is shown.  The protein 
migrated with a  relatively basic isoelectric point and ap- 
peared heterogeneous. In cells injected with microinjection 
buffer alone, little or no phosphorylated proteins could be 
observed in this region of the two-dimensional gels (Fig. 8 
E, arrowhead). However, after injection of A-kinase, a se- 
ries  of phosphorylated proteins  which migrated with the 
same coordinates as that determined for the MLCK were ob- 
served  (Fig.  8  F,  arrowhead).  Note  also  the  proteins 
directly under those designated by the arrowhead that ap- 
pear,  qualitatively, very similar to the intact MLCK. We 
suspect that these are proteolytic fragments of the intact pro- 
tein as others have previously reported (2, 39). Hence, after 
Lamb et al. cAMP-dependent  Kinase  and Microfilament  lntegri O,  1965 Figure 8. A-kinase-induced changes in MLCK and myosin light chain phosphorylation as determiend by Western blot analysis. REF-52 
cells growing on small (l-mm  2) glass coverslips were microinjected with either the catalytic subunit of A-kinase or with a control protein. 
30 min after injection the cells were labeled with [32p]H3PO4 for 30 min, harvested, and then mixed with an excess of unlabeled REF-52 
cells. The cell lysates were subjected to two-dimensional gel electrophoresis, the proteins transferred to nitrocellulose,  and the position 
of either MLCK or myosin light chain determined by incubation with the appropriate antibody and subsequent visualization with a second 
horseradish peroxidase-conjugated antibody, and color development (A and D). The nitrocellulose was then exposed to film to reveal the 
phosphate-labeled proteins. Shown in B, C, E, and Fare the autoradiogram. (A-C) Analysis of myosin light chain phosphorylation; A shows 
the position of the light chain as determined by immunoblotting, B the phosphate-labeled proteins in ceils injected with control proteins, 
and C the phosphate-labeled proteins in cells injected with A-kinase.  Note that only those portions of the gel analyzing myosin light chain 
are shown. (The position of the myosin light chain is indicated by an arrowhead.) (D-F) Analysis of MLCK phosphorylation; D  shows 
the position of MLCK as determined by immunoblotting, E the phosphate-labeled proteins in cells injected with control protein, and F 
the phosphate-labeled proteins in cells injected with A-kinase. Note that only those regions of the gel analyzing MLCK are shown. (The 
position of MLCK is indicated by an arrowhead.) 
A-kinase injection there occurred a transient increased phos- 
phorylation of MLCK and a corresponding decreased level 
of new  myosin light chain  phosphorylation. 
Effects of  Microinjection  of  Antibodies Specific 
for MLCK on Actin MF lntegrity and Myosin Light 
Chain Phosphorylation 
The data described  above are consistent  with  the  idea that 
phosphorylation of MLCK catalyzed by A-kinase could  re- 
suit  in  the  inactivation  of MLCK,  the  subsequent  dephos- 
phorylation of MLC,  and the dissolution  of the actomyosin 
MFs. Therefore, we chose to test the effect of directly inhibit- 
ing  MLCK activity  in vivo by injecting  antibodies  specific 
for the kinase into living cells. For these studies rabbit poly- 
clonal antibodies were affinity purified using native MLCK 
from smooth muscle. Before testing their efficacy in vivo, we 
tested the inhibitory activity of these antibodies on the Ca++/ 
calmodulin-dependent  phosphorylation  of purified  myosin 
The Journal of Cell  Biology, Volume 106,  1988  1966 Figure 9. Microinjection of antibodies specific to native MLCK results in the dephosphorylation of myosin light chain and the disassembly 
of the actin MFs. REF-52 cells growing on glass coverslips were microinjected with either affinity-purified MLCK antibody or with a 
nonspecific control, fluorescently labeled antibody. 45 min after injection the cells were fixed and analyzed for the distribution of the actin 
MFs using rh-phalloidin. In parallel, cells growing on l-mm  2 glass coverslips were injected with the same antibodies, and 45 min later 
labeled with [32p]I'I3PO4 for a period of 1 h. The cells were then harvested and the labeled proteins analyzed by two-dimensional gel elec- 
trophoresis. Insets in B and D are the regions of the autoradiograms covering the area of migration of myosin light chain. The position 
of the myosin light chain is indicated by an arrowhead. (A and B) Cells microinjected with control antibodies and stained for either the 
injected antibody (A) or the actin MFs (B). Inset in B shows the position of the myosin light chain in the cells injected with the control 
antibody and labeled with [s2P]HsPO4. (C and D) Cells microinjected with anti-MLCK and stained for the injected antibody (C) or the 
actin MFs (D). Inset in D shows the position of the myosin light chain in the cells injected with the anti-MLCK antibody and labeled 
with [32p]H3PO4. 
light  chain  by purified MLCK  in  vitro.  We  found that  a 
0.5-mg/ml solution of the affinity-purified anti-MLCK anti- 
body inhibited 90% of the Ca++/calmodulin-dependent phos- 
phorylation of MLC by purified MLCK. In contrast, up to 
10-mg/ml solutions of control IgGs had little or no effect on 
the kinase activity under the same assay conditions. To as- 
sess the effects of the inhibitory antibodies in vivo, REF-52 
cells, growing on glass coverslips, were injected with either 
control nonspecific antibodies (e.g., rabbit anti-rat IgG) or 
alternatively the  affinity-purified rabbit  anti-MLCK  anti- 
body. 45 min later, the cells were fixed and analyzed for the 
distribution of the actin MFs, using rh-phalloidin. To iden- 
tify the  injected cells,  the coverslips were incubated with 
fluorescein-labeled goat anti-rabbit antibody. Fig. 9, A and 
B, shows a field of about six cells, one of which was injected 
with the control IgG as shown by the fluorescent staining of 
the injected antibody (Fig. 9 A). All of the cells,  including 
the single cell injected with the control antibody, exhibited 
a normal distribution of actin MFs (B). Approximately 50 
such  injected cells  were examined after injection of non- 
specific IgGs, and all showed a normal distribution of actin 
MFs. Fig. 9, C and D shows a field of cells in which one cell 
was injected with the affinity-purified anti-MLCK antibody. 
Only that cell containing the MLCK antibody (C) showed 
a  loss of filamentous actin staining (D).  Of ,'~150 cells in- 
jected  with  affinity-purified  anti-MLCK,  at  least  95% 
showed such a complete loss of actin MF structure by 45 min 
after injection. Dilution of this antibody to ,'o25 p.g/ml abol- 
ished the effect on the microfilaments. Interestingly, cells in- 
jected with the affinity-purified MLCK antibody did not ex- 
hibit the same changes in cell morphology, such as the cell 
rounding observed after injection of A-kinase. Since in both 
cases the extent of actin reorganization appeared similar, ap- 
parently there must occur other changes in the cells after 
A-kinase injection that result in the rounded phenotype. 
Finally, to ascertain whether the changes in actin MF in- 
tegrity after injection of the MLCK antibody were correlated 
with changes in the phosphorylation status of myosin light 
chain,  phosphorylation studies  again  were performed. As 
described before, •100  cells on small coverslips were in- 
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affinity-purified anti-MLCK antibody; then the cells were la- 
beled with [32p]H3PO4 for ,,o30 min, and the labeled pro- 
teins analyzed by two-dimensional gel electrophoresis. Cells 
injected with the control antibodies exhibited a typical pat- 
tern of myosin light chain phosphorylation (Fig. 9 B, inset). 
In contrast, those cells injected with the anti-MLCK anti- 
body showed virtually no phosphorylated myosin light chain 
(Fig. 9 D, inset). Under these conditions, we observed no 
other major changes in protein phosphorylation such as that 
observed after microinjection of  A-kinase. Namely, injection 
of the antibody did not result in any increase in MLCK, 
lamin, or vimentin phosphorylation like that seen in cells in- 
jected with A-kinase. Therefore, inhibition of MLC phos- 
phorylation can occur either as a result of A-kinase-medi- 
ated phosphorylation of MLCK or alternatively by direct 
inhibition of MLCK activity via injection of anti-MLCK 
antibodies. 
Discussion 
Using the direct approach of microinjection, we have exam- 
ined the role of  A-kinase and MLCK in the regulation of  non- 
muscle cell structure and the integrity of actin MFs. Eleva- 
tion of A-kinase levels  via microinjection of the purified 
catalytic subunit of A-kinase resulted in cell rounding and 
dissolution of the microfilaments. Using metabolic labeling 
of phosphoproteins after A-kinase injection, we provide data 
implicating changes in the phosphorylation status of myosin 
light chain and MLCK as a potential molecular basis for the 
changes observed in MF integrity. 
Changes in Cellular Morphology after Elevation 
of  A-Kinase Activity 
A number of previous reports have detailed changes in cell 
morphology after activating endogenous A-kinase using ei- 
ther drugs or beta-adrenergic hormones (5). However, others 
(16, 44, 53, 72; reviewed in reference 43) have described op- 
posite morphological effects of elevating A-kinase activity in 
transformed cells, which they termed "reverse transforma- 
tion" (16, 43, 44, 53).  In these latter studies, cells were ob- 
served to flatten by 24 h after the administration of the drugs 
that activated A-kinase. 
We have studied the effects of elevating A-kinase levels in 
20 different cell lines, several  of which are transformed. In 
all cases, the predominant early effect of elevating endoge- 
nous A-kinase activity was to cause cells to round (with 
transformed cells appearing more rounded). These changes, 
which we observed during the first 6-12 h, were consistent 
whether using drugs,  beta-adrenergic  hormones,  or  after 
microinjection of A-kinase.  We found, however,  that cell 
rounding induced after inactivation of A-kinase via drug or 
hormone  treatment  was  often times  maintained only  for 
<24 h, after which time the cells reverted to their original 
flattened morphology and become refractory to further ex- 
posure to the drugs. However,  microinjection of these cells 
previously treated with drugs with A-kinase still resulted in 
cell rounding. Therefore, it would seem that the cell is capa- 
ble of "down-regulating" the levels of A-kinase. Others have 
suggested that specific mechanisms exist by which cells can 
modulate  the  level  of A-kinase  activity during  different 
phases of the cell cycle (38, 74) and down-regulation mecha- 
nisms have been proposed for A-kinase in fibroblasts (7, 38). 
This down-regulation may be analogous to that described for 
C-kinase where there is an apparent loss of C-kinase activity 
in cells after chronic exposure to one of its activators, phor- 
bol  myristate acetate (18).  Hence,  we  speculate that cell 
rounding was an early effect of the activation of A-kinase 
while cell flattening is a  long-term effect associated with 
down-regulation of A-kinase. 
Changes in MF Integrity and Protein Phosphorylation 
after Elevation of  A-Kinase Activity through 
Microinjection 
In addition to the effects on cell morphology, the present 
studies have detailed complex changes in the actin MF net- 
works after elevation of A-kinase activity. In the case of 
smooth muscle cells there is substantial evidence indicating 
a  role  for  A-kinase,  MLCK,  and  myosin light chain  in 
regulating the contractility of actomyosin (2, 4, 22, 29, 39, 
57,  66).  The  enzyme MLCK,  which  requires  Ca  ++  and 
calmodulin for its kinase activity, catalyzes the phosphoryla- 
tion of the regulatory or MLC (2, 21, 29, 36; reviewed in ref- 
erence 1, 39).  This phosphorylation of the MLC has been 
correlated with increases in both the actin-dependent Mg- 
ATPase  activity of myosin (reviewed in 22,  35)  and the 
avidity of the whole myosin complex for actin (68), resulting 
in  a  concomitant  stimulation  of  actomyosin  contraction 
and/or certain types of cell motility (3, 6, 24, 67). Because 
phosphorylated MLC has a short half-life in cells (2, 7, 22, 
39,  57,  66),  phosphorylation/dephosphorylation may pro- 
vide for rapid changes in the contractility of the actomyosin 
system. Interestingly, the enzyme MLCK has been colocal- 
ized with myosin along the length of the stress fibers, and, 
as such, would appear to be adequately situated to effect such 
a regulatory role (28).  Since the phosphorylation of MLCK 
by A-kinase can inhibit MLCK activity in vivo (26, 60), pre- 
sumably via inhibiting the binding of Ca÷+/calmodulin  to 
MLCK (1, 3, 21, 37, 47),  it has been suggested that cAMP 
plays a role in the regulation of smooth muscle contractility 
as  opposed  to  a  regulatory  mechanism  involving  solely 
Ca++/calmodulin  (22,  39, 66). 
We have shown that injection of A-kinase into living non- 
muscle  cells  results  in  an  increased  phosphorylation  of 
MLCK, a decreased incorporation of phosphate into MLC 
and a loss of actin MF bundles. Such data provides strong 
in vivo evidence for a role of cAMP and A-kinase in the regu- 
lation of actin MF assembly in nonmuscle cells through the 
increased phosphorylation of MLCK and a concomitant de- 
creased phosphorylation of the myosin light chain. However, 
it remains possible that as yet other unidentified phosphory- 
lation/dephosphorylation events may occur after injection of 
the purified A-kinase that may aid in the disassembly of the 
actin  filaments.  Indeed  we  did  observe  numerous  other 
changes in the phosphorylation status of various proteins af- 
ter  injection of A-kinase.  Although the injected A-kinase 
seems to cause a complete diassembly of the MFs, it is possi- 
ble that short, single MFs remain but are undetectable under 
the fixation conditions used here. We are currently address- 
ing this issue using fluorescent probes in living cells. 
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Phosphorylation after Microinjection of  Antibodies 
Directed against MLCK 
To address more directly the possible role of MLCK in the 
regulation  of the  MFs,  we  have  examined the  effect of 
specifically inactivating MLCK in vivo through the injection 
of inhibitory antibodies directed against it and have found 
that this inactivation is in of itself sufficient to cause both the 
dephosphorylation of MLC and the concomitant dissolution 
of  the actin MF bundles. We introduced a number of  antibod- 
ies  into living cells in addition to the antibodies directed 
against MLCK. Only affinity-purified anti-MLCK antibod- 
ies, which also inhibit MLCK activity in vitro, led to the re- 
organization of MF and MLC dephosphorylation, whereas 
a number of other purified antibodies directed against other 
MF-associated  proteins  had  no  such  effect.  These  data 
strongly  suggest  that  the  disassembly of MF  after  anti- 
MLCK injection results  from the  specific inactivation of 
MLCK and the consequent dephosphorylation of MLC as 
opposed to an effect involving solely the binding of the anti- 
bodies to the MLCK present in the MF bundles. These data, 
coupled to the results obtained after injection of A-kinase, 
appear to link the dephosphorylation of the MLC with the 
disassembly of the actin MFs in nonmuscle cells. While the 
molecular details governing the relationship between MLC 
phosphorylation and the integrity of the actin MF bundles 
are not completely clear, we can offer some speculation. If 
dephosphorylation of MLC has effects similar to those de- 
scribed in smooth muscle (i.e., reduces the myosin ATPase 
activity and avidity of the myosin head for actin), then we 
might suggest that the filament would become destabilized by 
the loss of phosphorylated MLC, thereby leading to the dis- 
assembly of  the actomyosin-containing  MFs. However, while 
these data imply the involvement of MLC phosphorylation 
in MF assembly/disassembly, they do not exclude the poten- 
tial role of any of the other MF-associated proteins in this 
process. Indeed, the dephosphorylation of MLC (after injec- 
tion of either A-kinase or the inhibitory antibodies) or the in- 
jection of the inhibitory antibodies, may well perturb the 
function or binding of any of the other MF-associated pro- 
teins (56) and thereby contribute to the destabilization of the 
actin microfilaments. 
Relationship of the Effects of  Drugs that Elevate 
Endogenous A-Kinase with that of  Microinjection of 
Exogenous A-Kinase 
While most of the cellular changes elicited by the drugs that 
elevate endogenous cAMP levels appeared similar to those 
observed after A-kinase injection, we did observe one dis- 
crepancy. As discussed above, in those cells microinjected 
with the enzyme, a reduced level of MLC phosphorylation 
was observed. Interestingly, however, in drug-treated cells the 
level of MLC phosphorylation was only slightly reduced or, 
in some experiments, unchanged (data not shown). This lat- 
ter finding is consistent with that of  Bayley and Rees (7), who 
showed that db-cAMP treatment of fibroblasts leads to only 
a  small and highly transient decrease in the level of MLC 
phosphorylation. While there are many possible explana- 
tions for this transient effect of the drugs on the level of phos- 
phorylation of the MLC, we suspect that this may be due to 
the phosphorylation of the MLC by kinases other than the 
MLCK, that are somehow affected or stimulated by the phar- 
macological agents. For example, at least four other protein 
kinases have been reported to phosphorylate MLC at differ- 
ent sites in vitro (61). We are currently performing peptide 
mapping analysis of the phosphorylated MLC to determine 
the sites of phosphorylation under the different conditions 
that lead to a dissolution of the actin MFs (i.e., drug-treated 
vs.  A-kinase-injected cells). 
In addition to the changes in MLC and MLCK phosphory- 
lation detailed above,  very obvious changes in the phos- 
phorylation status of vimentin also were observed in cells in- 
jected with A-kinase (Fig. 7, B-D). It is of interest to note 
that  immunofluorescence analysis  revealed  the  vimentin- 
containing intermediate filaments to rapidly collapse in and 
around the nucleus, and in some types dissolve altogether, 
shortly  after  A-kinase  injection  (data  not  shown).  Since 
others have implicated changes in the organization of inter- 
mediate filaments as a function of vimentin phosphorylation 
(12, 14, 17, 30, 31, 33, 41, 63), we are pursuing the possibility 
that the phosphorylation of vimentin, catalyzed via A-ki- 
nase, may serve to regulate intermediate filament integrity 
in these cells. Finally, with respect to the change in cell mor- 
phology, injection of A-kinase induced cell rounding, while 
injection of  the anti-MLCK had no obvious effect on the mor- 
phology of the cells.  Nevertheless, both treatments effec- 
tively induced the disassembly of the actin MFs. Taken to- 
gether with the effect of A-kinase on intermediate filaments, 
these results indicate, not too surprisingly, that cell shape is 
not determined solely by the integrity of the MFs but perhaps 
involves the contribution of both MF and intermediate fila- 
ment networks. 
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